|
|
| Directors’ Report |
Your Directors take pleasure in presenting the Sixteenth Annual Report and Audited Accounts for the year ended 31st March,
2008.
Dividend
An interim preference share dividend on pro-rata basis @ 6% p.a. had been declared on 25th Oct, 2007 on outstanding preference
shares and was paid on Nov 1, 2007. Your Directors recommend that the interim dividend on preference paid be treated as final.
Your Directors are pleased to recommend a equity dividend of 210% (previous year 135%) for the year ended 31st March, 2008
on the equity share capital.
Management Discussion and Analysis
The management discussion and analysis on the operations of the Company is provided in a separate section and forms part of
this report.
Human Resources
At Sun Pharma, we have grown to a committed workforce of over 8000 multi-cultural employees pursuing a shared vision of
excellence across our corporate office, two R&D centres & seventeen plants (including associate companies) across three
continents. Our consistent growth firmly establishes our remarkable team, their potential and capabilities to deliver. The
company recognizes the importance of human capital and search for this intellectual capital and to enrich professional and
technical skill is an ongoing process. Relentless efforts to develop and nurture through in-house, external professional
development programs and on-job training are used to upgrade technical, marketing and management skills. Performance
orientation and ethics are a high priority area. The work environment and development opportunities help to retain talent. Your
Directors recognize the team’s valuable contribution, nurtures with joy their more than 8000 people and place on record their
appreciation for Team Sun Pharma.
Information as per Section 217(2A) of the Companies Act, 1956, read with the Companies (Particulars of Employees) Rules, 1975
as amended, is available at the registered office of your Company. However, as per the provisions of Section 219(1)(b)(iv) of the
said Act, the Report and Accounts are being sent to all shareholders of the Company and others entitled thereto excluding the
aforesaid information. Any shareholder interested in obtaining a copy of this statement may write to the Company Secretary/Compliance Officer at the Corporate office or Registered office address of the Company.
Financial Result >> |
|
